RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research

Corporate filings · Event Monitor · Free for all

← Back

Pacira BioSciences, Inc.

PCRX

Pharmaceutical Preparations · SIC 2834 · CIK 0001396814

SHARE:XLINKEDINEMAIL
Revenue FY2025
$726.0M
Net Income
$7.0M
EPS (Basic)
$0.16
Net Margin
1.0%
ROE
1.0%
Total Equity
$693.0M
Shares Out
40M

Pacira BioSciences, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Revenue & Net Income (10Y)

Margin Trends

Investor Ownership · 1 fund in our universe

FundPosition Value% of AUMQoQ ChgWeight
Renaissance Technologies
Renaissance Technologies
$44.0M
0.0%
(5.0%)

Insider Transactions

Reading stored insider transactions…